Form 4: Aethlon Medical Director Acquires Shares Through Restricted Stock Units

Director Edward G. Broenniman acquired 142,857 shares of Aethlon Medical Inc. at $0.35 per share through the grant of Restricted Stock Units (RSUs).

Summary

• On April 23, 2025, Edward G. Broenniman, a director of Aethlon Medical Inc., acquired 142,857 shares of common stock.
• The acquisition was through the grant of Restricted Stock Units (RSUs) at a price of $0.35 per share.
• Following the transaction, Broenniman directly owns 181,741 shares of Aethlon Medical Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of share acquisition by a director, which is neither particularly positive nor negative on its own.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future prospects.

Future Outlook

The RSUs vest over time, incentivizing the director to remain with the company.

Industry Context

This is a standard SEC Form 4 filing, reflecting changes in beneficial ownership by a company insider. Such filings are common and provide transparency to the market.

Stakeholder Impact

• The transaction increases the director's stake in the company, aligning their interests with those of other shareholders.

Key Dates

Keywords

Aethlon Medical, Director, Share Acquisition, RSUs, Form 4, Beneficial Ownership, AEMD, Edward G. Broenniman